Assertio Holdings/$ASRT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Assertio Holdings
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Ticker
$ASRT
Sector
Primary listing
Employees
53
Headquarters
Website
ASRT Metrics
BasicAdvanced
$106M
-
-$4.74
0.79
-
Price and volume
Market cap
$106M
Beta
0.79
52-week high
$16.54
52-week low
$8.61
Average daily volume
68K
Financial strength
Current ratio
1.699
Quick ratio
1.439
Long term debt to equity
42.589
Total debt to equity
42.844
Interest coverage (TTM)
-5.60%
Profitability
EBITDA (TTM)
12.782
Gross margin (TTM)
70.19%
Net profit margin (TTM)
-25.59%
Operating margin (TTM)
-14.51%
Effective tax rate (TTM)
-1.45%
Revenue per employee (TTM)
$2,240,000
Management effectiveness
Return on assets (TTM)
-3.90%
Return on equity (TTM)
-28.25%
Valuation
Price to revenue (TTM)
0.89
Price to book
1.13
Price to tangible book (TTM)
2.35
Price to free cash flow (TTM)
-3.751
Free cash flow yield (TTM)
-26.66%
Free cash flow per share (TTM)
-4.401
Growth
Revenue change (TTM)
-5.00%
Earnings per share change (TTM)
39.61%
3-year revenue growth (CAGR)
-8.75%
10-year revenue growth (CAGR)
-10.06%
3-year earnings per share growth (CAGR)
-46.23%
10-year earnings per share growth (CAGR)
-24.18%
ASRT News
AllArticlesVideos
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
Business Wire·1 week ago
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Business Wire·3 weeks ago
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Assertio Holdings stock?
Assertio Holdings (ASRT) has a market cap of $106M as of March 25, 2026.
What is the P/E ratio for Assertio Holdings stock?
The price to earnings (P/E) ratio for Assertio Holdings (ASRT) stock is 0 as of March 25, 2026.
Does Assertio Holdings stock pay dividends?
No, Assertio Holdings (ASRT) stock does not pay dividends to its shareholders as of March 25, 2026.
When is the next Assertio Holdings dividend payment date?
Assertio Holdings (ASRT) stock does not pay dividends to its shareholders.
What is the beta indicator for Assertio Holdings?
Assertio Holdings (ASRT) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.